Phytochemical profile and neuropharmacological potential of Erythrina velutina Willd. (Fabaceae): An integrative preclinical review
Authors:
- Gabriela Acunha RazzeraGRGabriela Acunha Razzera
- Elize MusachioEMElize Musachio
- Fernanda dos Santos TrombiniFTFernanda dos Santos Trombini
- Cindhy Suely da Silva MedeirosCMCindhy Suely da Silva Medeiros
- Maria Denise SchimithMSMaria Denise Schimith
- Euler Esteves RibeiroEREuler Esteves Ribeiro
- Fernanda BarbisanFBFernanda Barbisan
Open Access
- 20 March 2026
- journal article
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 5 (4) , 1-14
Abstract
Medicinal plants constitute an important source of bioactive compounds for the discovery of novel neuroactive agents. Erythrina velutina Willd. (Fabaceae). Popularly known as mulungu, has been traditionally used in the treatment of anxiety, insomnia, and other conditions related to the central nervous system (CNS), which has motivated extensive pharmacological and preclinical investigations. This integrative review critically synthesizes the available evidence on the phytochemical profile and neuropharmacological potential of E. velutina. The literature search was conducted in PubMed, SciELO, Web of Science, and the Virtual Health Library, including preclinical in vitro and in vivo studies, with no language or publication-year restrictions. The analyzed studies indicate a complex phytochemical composition characterized primarily by alkaloids, flavonoids, and other phenolic compounds. Preclinical evidence demonstrates anxiolytic, sedative, anticonvulsant, antioxidant, neuroprotective, and anticholinesterase activities associated with modulation of GABAergic and cholinergic neurotransmission, as well as with reductions in oxidative stress and neuronal protection. The available toxicological data suggest low acute toxicity and the absence of genotoxic effects at the experimentally evaluated doses. However, the lack of standardized extracts, compound-guided pharmacological studies, long-term toxicological assessments, and clinical investigations limits the translational extrapolation of the findings. Therefore, future studies focused on bioprospecting, elucidation of mechanisms of action, and clinical validation are required to consolidate the pharmacological potential of Erythrina velutina.Keywords
This publication has 27 references indexed in Scilit:
- Erythrina velutina Willd.: A review of its traditional uses, phytochemistry, pharmacology, and toxicologyJournal of Ethnopharmacology, 2023
- Biotechnological potential of medicinal plant Erythrina velutina Willd: A systematic reviewBiocatalysis and Agricultural Biotechnology, 2022
- Effects of standard ethanolic extract from Erythrina velutina in acute cerebral ischemia in miceBiomedicine & Pharmacotherapy, 2017
- Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatmentNeuropharmacology, 2015
- Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-α-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex Benth (Leguminosae–Papilionaceae)Epilepsy & Behavior, 2011
- Evidence of the mechanism of action of Erythrina velutina Willd (Fabaceae) leaves aqueous extractJournal of Ethnopharmacology, 2009
- Hypaphorine, an indole alkaloid from Erythrina velutina, induced sleep on normal miceBioorganic & Medicinal Chemistry Letters, 2008
- Anticonvulsant activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulunguJournal of Ethnopharmacology, 2007
- Medicinal and magic plants from a public market in northeastern BrazilJournal of Ethnopharmacology, 2007
- Central nervous system effects of the crude extract of Erythrina velutina on rodentsJournal of Ethnopharmacology, 2004